Discover 1 curated intelligence briefings related to this specific topic.
As Indonesia opens regulatory windows for longevity medicine and global insurers begin covering blood-based Alzheimer's tests, the traditional tissue biopsy faces a reckoning. This evolution is not a sudden replacement but a strategic reordering of how we detect disease.
